Xact Kapitalforvaltning’s Supernus Pharmaceuticals SUPN Stock Holding History

Xact Kapitalforvaltning’s Portfolio SUPN Stock Details SUPN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	$180K	Hold	10,016	–	–	﹤0.01%	1219
2019 Q4	$238K	Hold	10,016	–	–	﹤0.01%	1328
2019 Q3	$275K	Hold	10,016	–	–	0.01%	1238
2019 Q2	$331K	Hold	10,016	–	–	0.01%	1164
2019 Q1	$351K	Hold	10,016	–	–	0.01%	1127
2018 Q4	$333K	Buy	10,016 +2,000	+25%	+$86K	0.01%	1167
2018 Q3	$404K	Hold	8,016	–	–	0.01%	1128
2018 Q2	$480K	Sell	8,016 -700	-8%	-$36.3K	0.01%	960
2018 Q1	$399K	Buy	+8,716	New	+$364K	0.01%	989

Other funds holding SUPN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

RHJA

Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Xact Kapitalforvaltning's SUPN Position: Q1 2020 in Review

Xact Kapitalforvaltning held its Supernus Pharmaceuticals (SUPN) position steady in Q1 2020 at 10,016 shares worth $180K. The position accounts for ﹤0.01% of the portfolio, ranked #1219.

Xact Kapitalforvaltning first reported a position in SUPN in Q1 2018 and has held it in 9 quarters since. The position peaked at $480K in Q2 2018. 208 funds tracked by Wall St. Rank hold SUPN as of Q1 2020.

Xact Kapitalforvaltning held 10,016 shares of Supernus Pharmaceuticals worth $180K as of Q1 2020.
Xact Kapitalforvaltning left its Supernus Pharmaceuticals share count unchanged in Q1 2020.
Supernus Pharmaceuticals made up ﹤0.01% of Xact Kapitalforvaltning's portfolio in Q1 2020, its #1219 holding.
Xact Kapitalforvaltning first reported a position in Supernus Pharmaceuticals in Q1 2018 and has held it in 9 quarters since.
Xact Kapitalforvaltning's Supernus Pharmaceuticals position peaked at $480K in Q2 2018.
208 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q1 2020.

Based on Xact Kapitalforvaltning's 13F filing for Q1 2020, filed 14 May 2020.